| scholarly article | Q13442814 |
| P50 | author | Lisa C Ranford-Cartwright | Q37382963 |
| Richard Carter | Q89224170 | ||
| P2093 | author name string | Saul A | |
| Cheng Q | |||
| Lawrence G | |||
| Stowers A | |||
| Reed C | |||
| Creasey A | |||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | malaria | Q12156 |
| Plasmodium falciparum | Q311383 | ||
| malaria vaccine | Q6741353 | ||
| P304 | page(s) | 495-500 | |
| P577 | publication date | 1997-10-01 | |
| P1433 | published in | American Journal of Tropical Medicine and Hygiene | Q15766943 |
| P1476 | title | Measurement of Plasmodium falciparum growth rates in vivo: a test of malaria vaccines | |
| P478 | volume | 57 |
| Q56347020 | A bioreactor system for the manufacture of a genetically modified Plasmodium falciparum blood stage malaria cell bank for use in a clinical trial |
| Q28476638 | A pilot randomised trial of induced blood-stage Plasmodium falciparum infections in healthy volunteers for testing efficacy of new antimalarial drugs |
| Q50318730 | A randomized feasibility trial comparing four antimalarial drug regimens to induce Plasmodium falciparum gametocytemia in the controlled human malaria infection model |
| Q36024472 | Analysis of Breath Specimens for Biomarkers of Plasmodium falciparum Infection |
| Q34407223 | Anti-malarial market and policy surveys in sub-Saharan Africa |
| Q36391845 | Can growth inhibition assays (GIA) predict blood-stage malaria vaccine efficacy? |
| Q37530299 | Challenges of assessing the clinical efficacy of asexual blood-stage Plasmodium falciparum malaria vaccines |
| Q42157454 | Characterization of the antibody response against Plasmodium falciparum erythrocyte membrane protein 1 in human volunteers |
| Q35990043 | Comparison of PCR-based detection of Plasmodium falciparum infections based on single and multicopy genes |
| Q36936348 | Comparison of modeling methods to determine liver-to-blood inocula and parasite multiplication rates during controlled human malaria infection |
| Q38607982 | Comparison of statistical models to estimate parasite growth rate in the induced blood stage malaria model |
| Q44168331 | Controlled Human Malaria Infection: Applications, Advances and Challenges. |
| Q38001604 | Controlled human blood stage malaria infection: current status and potential applications |
| Q37548076 | Cross-reactive immune responses as primary drivers of malaria chronicity |
| Q33570804 | Cross-species malaria immunity induced by chemically attenuated parasites |
| Q38582087 | Detection sensitivity and quantitation of Plasmodium falciparum var gene transcripts by real-time RT-PCR in comparison with conventional RT-PCR. |
| Q35354508 | Development of cultured Plasmodium falciparum blood-stage malaria cell banks for early phase in vivo clinical trial assessment of anti-malaria drugs and vaccines |
| Q35785754 | Differential changes in Plasmodium falciparum var transcription during adaptation to culture |
| Q56341995 | Diurnal variation in expired breath volatiles in malaria-infected and healthy volunteers |
| Q44156054 | Experimental human challenge infections can accelerate clinical malaria vaccine development |
| Q37463375 | Experimentally induced blood-stage Plasmodium vivax infection in healthy volunteers. |
| Q37209510 | Haplotype specific-sequencing reveals MBL2 association with asymptomatic Plasmodium falciparum infection |
| Q49220322 | High Level of Specific Anti-Plasmodium Falciparum Merozoite IgG1 Antibodies in Rural Asymptomatic Individuals of Dienga, South-Eastern Gabon |
| Q34075564 | High diversity and rapid changeover of expressed var genes during the acute phase of Plasmodium falciparum infections in human volunteers |
| Q36327112 | Identification and validation of tetracyclic benzothiazepines as Plasmodium falciparum cytochrome bc1 inhibitors |
| Q33974904 | Impact on malaria parasite multiplication rates in infected volunteers of the protein-in-adjuvant vaccine AMA1-C1/Alhydrogel+CPG 7909. |
| Q37199873 | Infectivity of Plasmodium falciparum in Malaria-Naive Individuals Is Related to Knob Expression and Cytoadherence of the Parasite |
| Q37818601 | Is vaccine the magic bullet for malaria elimination? A reality check |
| Q33592503 | Lack of association between maternal antibody and protection of African infants from malaria infection |
| Q27324132 | Linking Murine and Human Plasmodium falciparum Challenge Models in a Translational Path for Antimalarial Drug Development |
| Q37335480 | Low multiplication rates of African Plasmodium falciparum isolates and lack of association of multiplication rate and red blood cell selectivity with malaria virulence |
| Q36030583 | Marked Rise in the Prevalence of Asymptomatic Plasmodium falciparum Infection in Rural Gabon |
| Q30838965 | Measurement of parasitological data by quantitative real-time PCR from controlled human malaria infection trials at the Walter Reed Army Institute of Research |
| Q35680345 | Mosquitoes Reset Malaria Parasites |
| Q39474607 | Mutations in Plasmodium falciparum cytochrome b that are associated with atovaquone resistance are located at a putative drug-binding site |
| Q34110755 | Mutations in cytochrome b resulting in atovaquone resistance are associated with loss of fitness in Plasmodium falciparum |
| Q33758001 | Only viable parasites are detected by PCR following clearance of rodent malarial infections by drug treatment or immune responses. |
| Q34427744 | P. falciparum infection durations and infectiousness are shaped by antigenic variation and innate and adaptive host immunity in a mathematical model |
| Q37390451 | Phase I/II evaluation of the prophylactic antimalarial activity of pafuramidine in healthy volunteers challenged with Plasmodium falciparum sporozoites. |
| Q35025427 | Physical linkage to drug resistance genes results in conservation of var genes among West Pacific Plasmodium falciparum isolates |
| Q37003081 | Piperaquine Monotherapy of Drug-Susceptible Plasmodium falciparum Infection Results in Rapid Clearance of Parasitemia but Is Followed by the Appearance of Gametocytemia. |
| Q28066456 | Plasmodium vivax Controlled Human Malaria Infection - Progress and Prospects |
| Q36835495 | Protection against malaria after immunization by chloroquine prophylaxis and sporozoites is mediated by preerythrocytic immunity |
| Q36509807 | Quinine treatment selects the pfnhe-1 ms4760-1 polymorphism in Malian patients with Falciparum malaria |
| Q33725604 | Rapid and highly sensitive detection of malaria-infected erythrocytes using a cell microarray chip |
| Q28478613 | Resistance of a rodent malaria parasite to a thymidylate synthase inhibitor induces an apoptotic parasite death and imposes a huge cost of fitness |
| Q36215894 | Safety and Reproducibility of a Clinical Trial System Using Induced Blood Stage Plasmodium vivax Infection and Its Potential as a Model to Evaluate Malaria Transmission |
| Q41946226 | Short RNA half-lives in the slow-growing marine cyanobacterium Prochlorococcus. |
| Q38973548 | Sporozoite Route of Infection Influences In Vitro var Gene Transcription of Plasmodium falciparum Parasites From Controlled Human Infections. |
| Q31064063 | Sulfadoxine resistance in Plasmodium vivax is associated with a specific amino acid in dihydropteroate synthase at the putative sulfadoxine-binding site |
| Q36247418 | The Power of Malaria Vaccine Trials Using Controlled Human Malaria Infection |
| Q35030175 | Time-to-infection by Plasmodium falciparum is largely determined by random factors. |
| Q35142959 | Ultra-sensitive detection of Plasmodium falciparum by amplification of multi-copy subtelomeric targets |
| Q34260722 | Vaccination of monkeys with recombinant Plasmodium falciparum apical membrane antigen 1 confers protection against blood-stage malaria |
| Q36914971 | Variation in infection length and superinfection enhance selection efficiency in the human malaria parasite |
| Q38762695 | Viral Vector Malaria Vaccines Induce High-Level T Cell and Antibody Responses in West African Children and Infants |
| Q27974124 | clag9: A cytoadherence gene in Plasmodium falciparum essential for binding of parasitized erythrocytes to CD36 |
| Q40130649 | pfcrt Allelic types with two novel amino acid mutations in chloroquine-resistant Plasmodium falciparum isolates from the Philippines |
Search more.